documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
460 rows where docket_id = "FDA-2013-N-1524" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 4
agency_id 1
- FDA 460
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-1524-2161 | FDA | None FDA-2013-N-1524 | Nomination Letter Riboflavin-5-Phosphate Sodium USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:41Z | 0 | 0 | 0900006481c24830 | |||
| FDA-2013-N-1524-2169 | FDA | None FDA-2013-N-1524 | Nomination Letter Selegiline HCl re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:43Z | 0 | 0 | 0900006481c24abf | |||
| FDA-2013-N-1524-2178 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Acetate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:50Z | 0 | 0 | 0900006481c24b91 | |||
| FDA-2013-N-1524-2168 | FDA | None FDA-2013-N-1524 | Nomination Letter SerAqua Serum re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:43Z | 0 | 0 | 0900006481c24abe | |||
| FDA-2013-N-1524-2155 | FDA | None FDA-2013-N-1524 | Nomination Letter Pyridoxine Hydrochloride USP (Vitamin B6 HCl) re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:37Z | 0 | 0 | 0900006481c24803 | |||
| FDA-2013-N-1524-2173 | FDA | None FDA-2013-N-1524 | Nomination Letter Silver Nitrate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:44Z | 0 | 0 | 0900006481c24ac7 | |||
| FDA-2013-N-1524-2200 | FDA | None FDA-2013-N-1524 | Nomination Letter Spermaceti Synthetic re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:07Z | 0 | 0 | 0900006481c24ce3 | |||
| FDA-2013-N-1524-2201 | FDA | None FDA-2013-N-1524 | Nomination Letter Spironolactone re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:07Z | 0 | 0 | 0900006481c24ce4 | |||
| FDA-2013-N-1524-2206 | FDA | None FDA-2013-N-1524 | Nomination Letter SSSF re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:08Z | 0 | 0 | 0900006481c24dba | |||
| FDA-2013-N-1524-2186 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Bromide Gran Pure re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c2d | |||
| FDA-2013-N-1524-2166 | FDA | None FDA-2013-N-1524 | Nomination Letter Salicylic Acid re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:43Z | 0 | 0 | 0900006481c24835 | |||
| FDA-2013-N-1524-2159 | FDA | None FDA-2013-N-1524 | Nomination Letter Resorcinol Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:41Z | 0 | 0 | 0900006481c2482e | |||
| FDA-2013-N-1524-2172 | FDA | None FDA-2013-N-1524 | Nomination Letter Shea Butter re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:44Z | 0 | 0 | 0900006481c24ac6 | |||
| FDA-2013-N-1524-2170 | FDA | None FDA-2013-N-1524 | Nomination Letter Sertraline HCL re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:44Z | 0 | 0 | 0900006481c24ac0 | |||
| FDA-2013-N-1524-2171 | FDA | None FDA-2013-N-1524 | Nomination Letter Sesame Oil re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:44Z | 0 | 0 | 0900006481c24ac1 | |||
| FDA-2013-N-1524-2181 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Benzoate Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:50Z | 0 | 0 | 0900006481c24b94 | |||
| FDA-2013-N-1524-2165 | FDA | None FDA-2013-N-1524 | Nomination Letter Safflower Oil re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:42Z | 0 | 0 | 0900006481c24834 | |||
| FDA-2013-N-1524-2160 | FDA | None FDA-2013-N-1524 | Nomination Letter Riboflavin USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:41Z | 0 | 0 | 0900006481c2482f | |||
| FDA-2013-N-1524-2183 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Bicarbonate USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:50Z | 0 | 0 | 0900006481c24c29 | |||
| FDA-2013-N-1524-2205 | FDA | None FDA-2013-N-1524 | Nomination Letter SSSF Omeprazole Kit re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:08Z | 0 | 0 | 0900006481c24db9 | |||
| FDA-2013-N-1524-2180 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Acetate USP Trihydrate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:50Z | 0 | 0 | 0900006481c24b93 | |||
| FDA-2013-N-1524-2199 | FDA | None FDA-2013-N-1524 | Nomination Letter Soybean Oil re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:07Z | 0 | 0 | 0900006481c24ce2 | |||
| FDA-2013-N-1524-2207 | FDA | None FDA-2013-N-1524 | Nomination Letter Starch Corn re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:08Z | 0 | 0 | 0900006481c24dbb | |||
| FDA-2013-N-1524-2196 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Valproate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:05Z | 0 | 0 | 0900006481c24c93 | |||
| FDA-2013-N-1524-2157 | FDA | None FDA-2013-N-1524 | Nomination Letter Quinacrine Hydrochloride re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:40Z | 0 | 0 | 0900006481c24805 | |||
| FDA-2013-N-1524-2193 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Propionate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:52Z | 0 | 0 | 0900006481c24c8f | |||
| FDA-2013-N-1524-2192 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Lauryl Sulfate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:52Z | 0 | 0 | 0900006481c24c8e | |||
| FDA-2013-N-1524-2202 | FDA | None FDA-2013-N-1524 | Nomination Letter Squalane re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:07Z | 0 | 0 | 0900006481c24ce5 | |||
| FDA-2013-N-1524-2174 | FDA | None FDA-2013-N-1524 | Nomination Letter Silicon Dioxide, Colloidal re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:48Z | 0 | 0 | 0900006481c24b8d | |||
| FDA-2013-N-1524-2176 | FDA | None FDA-2013-N-1524 | Nomination Letter Silver Sulfadiazine re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:49Z | 0 | 0 | 0900006481c24b8f | |||
| FDA-2013-N-1524-2203 | FDA | None FDA-2013-N-1524 | Nomination Letter SSSF Alka re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:07Z | 0 | 0 | 0900006481c24ce7 | |||
| FDA-2013-N-1524-2204 | FDA | None FDA-2013-N-1524 | Nomination Letter Squaric Acid re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:07Z | 0 | 0 | 0900006481c24ce8 | |||
| FDA-2013-N-1524-2182 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Ascorbate USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:50Z | 0 | 0 | 0900006481c24c28 | |||
| FDA-2013-N-1524-2198 | FDA | None FDA-2013-N-1524 | Nomination Letter Sorbitol Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:06Z | 0 | 0 | 0900006481c24ce1 | |||
| FDA-2013-N-1524-2162 | FDA | None FDA-2013-N-1524 | Nomination Letter Rifampin USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:42Z | 0 | 0 | 0900006481c24831 | |||
| FDA-2013-N-1524-2156 | FDA | None FDA-2013-N-1524 | Nomination Letter Pyruvic Acid re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:38Z | 0 | 0 | 0900006481c24804 | |||
| FDA-2013-N-1524-2184 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Bisulfite USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c2a | |||
| FDA-2013-N-1524-2185 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Borate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c2b | |||
| FDA-2013-N-1524-2197 | FDA | None FDA-2013-N-1524 | Nomination Letter Sorbic Acid Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:06Z | 0 | 0 | 0900006481c24c94 | |||
| FDA-2013-N-1524-2167 | FDA | None FDA-2013-N-1524 | Nomination Letter Scopolamine re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:43Z | 0 | 0 | 0900006481c24836 | |||
| FDA-2013-N-1524-2188 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Chloride USP Granular re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c2f | |||
| FDA-2013-N-1524-2164 | FDA | None FDA-2013-N-1524 | Nomination Letter Saccharin Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:42Z | 0 | 0 | 0900006481c24833 | |||
| FDA-2013-N-1524-2158 | FDA | None FDA-2013-N-1524 | Nomination Letter Rapid Dissolve Tablet Powder re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:40Z | 0 | 0 | 0900006481c2482d | |||
| FDA-2013-N-1524-2190 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Citrate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c8b | |||
| FDA-2013-N-1524-2194 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Phosphate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:52Z | 0 | 0 | 0900006481c24c90 | |||
| FDA-2013-N-1524-2195 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Sulfite re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:40:05Z | 0 | 0 | 0900006481c24c92 | |||
| FDA-2013-N-1524-2163 | FDA | None FDA-2013-N-1524 | Nomination Letter Rose Oil Artificial re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T14:33:42Z | 0 | 0 | 0900006481c24832 | |||
| FDA-2013-N-1524-2191 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Hydroxide NF Pellets re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:52Z | 0 | 0 | 0900006481c24c8d | |||
| FDA-2013-N-1524-2189 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Fluoride Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c31 | |||
| FDA-2013-N-1524-2177 | FDA | None FDA-2013-N-1524 | Nomination Letter Simethicone re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:49Z | 0 | 0 | 0900006481c24b90 | |||
| FDA-2013-N-1524-2179 | FDA | None FDA-2013-N-1524 | Nomination Letter Simple Syrup re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:50Z | 0 | 0 | 0900006481c24b92 | |||
| FDA-2013-N-1524-2175 | FDA | None FDA-2013-N-1524 | Nomination Letter Silver Protein Mild re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:49Z | 0 | 0 | 0900006481c24b8e | |||
| FDA-2013-N-1524-2187 | FDA | None FDA-2013-N-1524 | Nomination Letter Sodium Butyrate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-09T04:00:00Z | 2015 | 10 | 2015-10-09T15:18:51Z | 0 | 0 | 0900006481c24c2e | |||
| FDA-2013-N-1524-2148 | FDA | None FDA-2013-N-1524 | Nomination Letter Progesterone, Micronized re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:55Z | 0 | 0 | 0900006481c247fc | |||
| FDA-2013-N-1524-2123 | FDA | None FDA-2013-N-1524 | Nomination Letter Polysorbate 80 re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:32Z | 0 | 0 | 0900006481c1d85f | |||
| FDA-2013-N-1524-2122 | FDA | None FDA-2013-N-1524 | Nomination Letter Polysorbate 20 re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:32Z | 0 | 0 | 0900006481c1d85e | |||
| FDA-2013-N-1524-2105 | FDA | None FDA-2013-N-1524 | Nomination Letter Phenobarbital USP CIV re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:11Z | 0 | 0 | 0900006481c1d710 | |||
| FDA-2013-N-1524-2127 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Chloride USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:33Z | 0 | 0 | 0900006481c1d425 | |||
| FDA-2013-N-1524-2116 | FDA | None FDA-2013-N-1524 | Nomination Letter Piroxicam re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d807 | |||
| FDA-2013-N-1524-2120 | FDA | None FDA-2013-N-1524 | Nomination Letter Polybase re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:30Z | 0 | 0 | 0900006481c1d85b | |||
| FDA-2013-N-1524-2124 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Hydroxide re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:33Z | 0 | 0 | 0900006481c1d861 | |||
| FDA-2013-N-1524-2143 | FDA | None FDA-2013-N-1524 | Nomination Letter Pregnenolone re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:54Z | 0 | 0 | 0900006481c24a3c | |||
| FDA-2013-N-1524-2095 | FDA | None FDA-2013-N-1524 | Nomination Letter Pentravan re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T14:23:49Z | 0 | 0 | 0900006481c1a814 | |||
| FDA-2013-N-1524-2139 | FDA | None FDA-2013-N-1524 | Nomination Letter Prednisolone Acetate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:53Z | 0 | 0 | 0900006481c24a38 | |||
| FDA-2013-N-1524-2145 | FDA | None FDA-2013-N-1524 | Nomination Letter Prilocaine Hydrochloride USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:54Z | 0 | 0 | 0900006481c24a3e | |||
| FDA-2013-N-1524-2146 | FDA | None FDA-2013-N-1524 | Nomination Letter Prochlorperazine Maleate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:55Z | 0 | 0 | 0900006481c24a3f | |||
| FDA-2013-N-1524-2125 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Bicarbonate Gran re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:33Z | 0 | 0 | 0900006481c1d862 | |||
| FDA-2013-N-1524-2126 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Bromide Cry re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:33Z | 0 | 0 | 0900006481c1d424 | |||
| FDA-2013-N-1524-2154 | FDA | None FDA-2013-N-1524 | Nomination Letter Propylparaben re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:56Z | 0 | 0 | 0900006481c24802 | |||
| FDA-2013-N-1524-2150 | FDA | None FDA-2013-N-1524 | Nomination Letter Progesterone, Wettable re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:55Z | 0 | 0 | 0900006481c247fe | |||
| FDA-2013-N-1524-2093 | FDA | None FDA-2013-N-1524 | Nomination Letter Petrolatum Yellow re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T14:23:48Z | 0 | 0 | 0900006481c1a817 | |||
| FDA-2013-N-1524-2110 | FDA | None FDA-2013-N-1524 | Nomination Letter Phenyl Salicylate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d715 | |||
| FDA-2013-N-1524-2109 | FDA | None FDA-2013-N-1524 | Nomination Letter Phentolamine Mesylate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d714 | |||
| FDA-2013-N-1524-2131 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Hydroxide Pellets re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:34Z | 0 | 0 | 0900006481c1d429 | |||
| FDA-2013-N-1524-2130 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Gluconate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:33Z | 0 | 0 | 0900006481c1d428 | |||
| FDA-2013-N-1524-2100 | FDA | None FDA-2013-N-1524 | Nomination Letter Pharmabase Cosmetic Cream Heavy re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:10Z | 0 | 0 | 0900006481c1d245 | |||
| FDA-2013-N-1524-2142 | FDA | None FDA-2013-N-1524 | Nomination Letter Prednisolone Sodium re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:54Z | 0 | 0 | 0900006481c24a3b | |||
| FDA-2013-N-1524-2153 | FDA | None FDA-2013-N-1524 | Nomination Letter Psyllium Husk Pwd re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:56Z | 0 | 0 | 0900006481c24801 | |||
| FDA-2013-N-1524-2149 | FDA | None FDA-2013-N-1524 | Nomination Letter Promethazine HCl USP re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:55Z | 0 | 0 | 0900006481c247fd | |||
| FDA-2013-N-1524-2121 | FDA | None FDA-2013-N-1524 | Nomination Letter Polyoxyl 40 Stearate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:32Z | 0 | 0 | 0900006481c1d85c | |||
| FDA-2013-N-1524-2113 | FDA | None FDA-2013-N-1524 | Nomination Letter Phenytoin re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d804 | |||
| FDA-2013-N-1524-2103 | FDA | None FDA-2013-N-1524 | Nomination Letter Pharmabase Vaginal Cream re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:11Z | 0 | 0 | 0900006481c1d70d | |||
| FDA-2013-N-1524-2108 | FDA | None FDA-2013-N-1524 | Nomination Letter Phentermine HCl re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:11Z | 0 | 0 | 0900006481c1d713 | |||
| FDA-2013-N-1524-2097 | FDA | None FDA-2013-N-1524 | Nomination Letter Pentravan Plus re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T14:23:50Z | 0 | 0 | 0900006481c1a812 | |||
| FDA-2013-N-1524-2096 | FDA | None FDA-2013-N-1524 | Nomination Letter Peruvian Balsam Plus re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T14:23:50Z | 0 | 0 | 0900006481c1a813 | |||
| FDA-2013-N-1524-2112 | FDA | None FDA-2013-N-1524 | Nomination Letter Phenytoin Sodium re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d802 | |||
| FDA-2013-N-1524-2117 | FDA | None FDA-2013-N-1524 | Nomination Letter Podophyllum Resin Usp re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:13Z | 0 | 0 | 0900006481c1d808 | |||
| FDA-2013-N-1524-2104 | FDA | None FDA-2013-N-1524 | Nomination Letter Pharmabase CC NEC re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:11Z | 0 | 0 | 0900006481c1d70e | |||
| FDA-2013-N-1524-2135 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Sorbate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:34Z | 0 | 0 | 0900006481c1d42d | |||
| FDA-2013-N-1524-2141 | FDA | None FDA-2013-N-1524 | Nomination Letter Prednisone micr re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:54Z | 0 | 0 | 0900006481c24a3a | |||
| FDA-2013-N-1524-2151 | FDA | None FDA-2013-N-1524 | Nomination Letter Propranolol HCl re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:56Z | 0 | 0 | 0900006481c247ff | |||
| FDA-2013-N-1524-2099 | FDA | None FDA-2013-N-1524 | Nomination Letter Peg re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T14:23:50Z | 0 | 0 | 0900006481c1a810 | |||
| FDA-2013-N-1524-2111 | FDA | None FDA-2013-N-1524 | Nomination Letter Phenylephrine re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d801 | |||
| FDA-2013-N-1524-2114 | FDA | None FDA-2013-N-1524 | Nomination Letter Phosphatidyl Serine 20% re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:12Z | 0 | 0 | 0900006481c1d805 | |||
| FDA-2013-N-1524-2119 | FDA | None FDA-2013-N-1524 | Nomination Letter Poloxamer 407 re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:29Z | 0 | 0 | 0900006481c1d85a | |||
| FDA-2013-N-1524-2106 | FDA | None FDA-2013-N-1524 | Nomination Letter Phenol re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:14:11Z | 0 | 0 | 0900006481c1d711 | |||
| FDA-2013-N-1524-2133 | FDA | None FDA-2013-N-1524 | Nomination Letter Potassium Permanganate re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T15:54:34Z | 0 | 0 | 0900006481c1d42b | |||
| FDA-2013-N-1524-2136 | FDA | None FDA-2013-N-1524 | Nomination Letter Povidone K-30 re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:52Z | 0 | 0 | 0900006481c24070 | |||
| FDA-2013-N-1524-2140 | FDA | None FDA-2013-N-1524 | Nomination Letter Prednisolone Anhy Micro re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T16:29:53Z | 0 | 0 | 0900006481c24a39 | |||
| FDA-2013-N-1524-2094 | FDA | None FDA-2013-N-1524 | Nomination Letter Petrolatum White re: Comment from Fagron | Supporting & Related Material | Background Material | 2015-10-08T04:00:00Z | 2015 | 10 | 2015-10-08T14:23:48Z | 0 | 0 | 0900006481c1a815 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;